AbbVie | ABBV - Current Assets

Abbvie reported $30.36B in Current Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Current Assets Change
ALKERMES ALKS:US USD 1.26B 208.12M
Amgen AMGN:US USD 22.19B 1.88B
AstraZeneca AZN:LN USD 22.59B 2.37B
Astrazeneca AZN:US USD 22.59B 2.37B
Biogen BIIB:US USD 9.79B 25.4M
Biomarin Pharmaceutical BMRN:US USD 2.75B 68.76M
Coherus Biosciences CHRS:US USD 381.23M 67.04M
Eisai 4523:JP JPY 610.12B 24.74B
Endo International Ordinary Shares ENDP:US USD 2.05B 145.74M
Gilead Sciences GILD:US USD 15.23B 1.67B
GlaxoSmithKline GSK:LN GBP 20.77B 520M
Horizon Pharma HZNP:US USD 3.65B 240.83M
Infinity Pharmaceuticals INFI:US USD 49.35M 10.26M
Intercept Pharmaceuticals ICPT:US USD 540.13M 5.24M
JAZZ PHA JAZZ:US USD 2.61B 34.64M
Medtronic MDT:US USD 25.36B 34M
Neurocrine Biosciences NBIX:US USD 1.45B 248M
Novartis NOVN:VX USD 36.91B 44M
Pacira Pharmaceuticals PCRX:US USD 498.33M 35.08M
Perrigo Ordinary Shares PRGO:US USD 2.72B 136.6M
Regeneron Pharmaceuticals REGN:US USD 22.06B 6.64B
Revance Therapeutics RVNC:US USD 374.73M 40.87M
Roche Holding ROG:VX 33.82B 3.5B
Teva Pharmaceutical Industries TEVA:US USD 12.05B 598M
Ultragenyx Pharmaceutical RARE:US USD 883.9M 128.77M
United Therapeutics UTHR:US USD 3.38B 323.9M
Vertex Pharmaceuticals VRTX:US USD 12.68B 410.3M
Zoetis ZTS:US USD 7.51B 955M